body.kc-css-system .kc-css-4223533{margin-top: 30px;padding-top: 38px;}body.kc-css-system .kc-css-133719 .section-title h2,body.kc-css-system .kc-css-133719 .title_tx h2{font-size: 1.4em;padding-top: 27px;}body.kc-css-system .kc-css-133719 .section-title h2 span,body.kc-css-system .kc-css-133719 .title_tx h2 span,body.kc-css-system .kc-css-133719 .em-icon i{color: #973333;}body.kc-css-system .kc-css-647666
J&J Vaccine Review (and authorization?) Coming Today Key Points: In today’s Recommendations for Industry, we discuss the J&J vaccine being reviewed for EUA by FDA
Key Points: In today’s Recommendations for Industry, we discuss post-vaccine symptomatic return to work for those receiving the vaccine and not feeling well. In addition,
body.kc-css-system .kc-css-2490960{margin-top: 30px;padding-top: 38px;}body.kc-css-system .kc-css-2016064 .section-title h2,body.kc-css-system .kc-css-2016064 .title_tx h2{font-size: 1.4em;padding-top: 27px;}body.kc-css-system .kc-css-2016064 .section-title h2 span,body.kc-css-system .kc-css-2016064 .title_tx h2 span,body.kc-css-system .kc-css-2016064 .em-icon i{color: #973333;}body.kc-css-system .kc-css-144448
body.kc-css-system .kc-css-498039{margin-top: 30px;padding-top: 38px;}body.kc-css-system .kc-css-3986610 .section-title h2,body.kc-css-system .kc-css-3986610 .title_tx h2{font-size: 1.4em;padding-top: 27px;}body.kc-css-system .kc-css-3986610 .section-title h2 span,body.kc-css-system .kc-css-3986610 .title_tx h2 span,body.kc-css-system .kc-css-3986610 .em-icon i{color: #973333;}body.kc-css-system .kc-css-1739315
Key Points: In today’s Recommendations for Industry, we discuss the TAG COVID-19 Risk Matrix showing that cases and case rates are dropping in the U.S.
body.kc-css-system .kc-css-1581081{margin-top: 30px;padding-top: 38px;}body.kc-css-system .kc-css-3529886 .section-title h2,body.kc-css-system .kc-css-3529886 .title_tx h2{font-size: 1.4em;padding-top: 27px;}body.kc-css-system .kc-css-3529886 .section-title h2 span,body.kc-css-system .kc-css-3529886 .title_tx h2 span,body.kc-css-system .kc-css-3529886 .em-icon i{color: #973333;}body.kc-css-system .kc-css-2018304
body.kc-css-system .kc-css-2101631{margin-top: 30px;padding-top: 38px;}body.kc-css-system .kc-css-356345 .section-title h2,body.kc-css-system .kc-css-356345 .title_tx h2{font-size: 1.4em;padding-top: 27px;}body.kc-css-system .kc-css-356345 .section-title h2 span,body.kc-css-system .kc-css-356345 .title_tx h2 span,body.kc-css-system .kc-css-356345 .em-icon i{color: #973333;}body.kc-css-system .kc-css-729807
COVID-19: Where We Were, Are, and Expect to Be One year ago this month, the TAG team came together (in person!) from across the U.S.
